Home > Research > Publications & Outputs > Human chromosome 17 in essential hypertension
View graph of relations

Human chromosome 17 in essential hypertension

Research output: Contribution to journalJournal articlepeer-review

Published
  • Jo Knight
  • P. B. Munroe
  • J. C. Pembroke
  • M. J. Caulfield
Close
<mark>Journal publication date</mark>03/2003
<mark>Journal</mark>Annals of Human Genetics
Issue number2
Volume67
Number of pages14
Pages (from-to)193-206
Publication StatusPublished
Early online date7/03/03
<mark>Original language</mark>English

Abstract

Hypertension affects up to 30% of the adult population in Western societies and is a major risk factor for kidney disease, stroke and coronary heart disease. It is a complex trait thought to be influenced by a number of genes and environmental factors, although the precise aetiology remains unknown at this time. A number of methods have been successfully used to identify mutations that cause Mendelian traits and these are now being applied to the investigation of complex diseases. This review summarises the data gathered, using such approaches, that suggest there is a gene or genes on chromosome 17 causing human essential hypertension. Studies in rodent models are discussed first, followed by studies of human hypertension that include the investigation of pseudohypoaldosteronism type II, a monogenic trait that manifests with hypertension alongside other phenotypic variables. In addition, candidate gene studies, genome screens and linkage studies based on comparative mapping are outlined. To date no gene has been identified on human chromosome 17 that influences blood pressure and causes human essential hypertension. However, results of ongoing fine mapping and candidate gene studies in both rodents and man are eagerly awaited.